✦ LIBER ✦

Comparison of benefit–risk profiles for adalimumab, methotrexate, and placebo in the treatment of moderate to severe psoriasis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of benefit–risk profiles with

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Benefit–risk outcomes with adalimumab ve

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Risk-benefit analysis of adalimumab vers

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Benefit-risk analysis of adalimumab vers

✍ Kristian Reich; James Signorovitch; Karthik Ramakrishnan; Andrew P. Yu; Eric Q. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Adalimumab treatment for moderate psoria

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Adalimumab for treatment of moderate to

✍ M. R. Bongiorno; G. Pistone; S. Doukaki; M. Aricò 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 963 KB